If the opening day of BioJapan 2026 diagnosed the gap between Japanese science and global deals, the second day at PACIF...
Yokohama, 7 October 2026 | BioJapan 2026, Regenerative Medicine JAPAN and healthTECH JAPAN, PACIFICO Yokoham...
As Asia Pacific economies grapple with ageing populations, shrinking workforces and rising healthcare expenditure, they ...
Neurology, once considered the graveyard of pharma development, is entering a new era. After years of high clinical fail...
On March 13, 2026, China’s National Medical Products Administration (NMPA) granted Class III registration to NEO, ...
China is emerging as one of the world's most dynamic markets for neuroscience and mental health technologies. Driven by ...
The success of mRNA vaccines during the COVID-19 pandemic transformed the technology from a promising scientific approac...
What were some of the most distinctive healthcare and medtech innovations from Taiwan showcased at Medical Fair Asia 202...
Which industries and applications will be the primary beneficiaries of the resins manufactured in Quzhou? The primary b...
How do you see the relationship between Tenthpin's India Innovation Hub and its established Japan operations, particular...
How do you view the multiple myeloma market in APAC, addressing its affordability and accessibility? Asia Pacific is at...
Avantor India has been appointed the exclusive distributor of Parafilm M in India, a product that is almost ubiquitous i...
Tenthpin has positioned Bengaluru as both an innovation and delivery hub. What does this mean in practical terms, and wh...
The latest personalised mRNA cancer vaccine data have renewed attention on individualized oncology. How significant is t...
As Asia-Pacific’s manufacturing landscape becomes more sophisticated, purification and separation technolo...
When we designed the small animal holding facility in 2012, we were solving a problem most facility planners preferred t...
Ask anyone who negotiates drug licences for a living what changed in the last two years, and you will usually get the sa...
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most difficult cancers to treat, creating an urgent need for ...
BioSpectrum Asia has published The CEO Handbook 2026, a seventy two page Career Spotlight edition profiling fifty chief ...
Every planning season produces the same quiet moment. The forecasts are built, the templates have gone around twice, and...
Isotope analysis is moving beyond specialised laboratories towards broader, molecular-level applications. In this BioSpe...
EVENT WRAP-UP | ASIA BIO PARTNERING FORUM 2026 A forum that met the moment Some conferences describe the industry. The...
"Almost every company preparing for a partnering conversation prepares for the wrong gate. The rejection usually happens...
Before we discuss the market, can you tell us about your role and what drew you to this area of healthcare logistics? I...
A session billed as a conversation about partnering was, on closer inspection, something rather more useful: a pricing s...
